IRIS
TASSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.728
AS - Asia 1.224
NA - Nord America 1.169
Continente sconosciuto - Info sul continente non disponibili 230
SA - Sud America 107
AF - Africa 30
OC - Oceania 1
Totale 11.489
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.535
US - Stati Uniti d'America 1.096
SG - Singapore 499
CN - Cina 346
VN - Vietnam 201
FR - Francia 64
BD - Bangladesh 60
BR - Brasile 56
HK - Hong Kong 42
FI - Finlandia 36
CA - Canada 28
DE - Germania 28
AR - Argentina 22
JP - Giappone 18
MX - Messico 17
GB - Regno Unito 13
IQ - Iraq 10
ZA - Sudafrica 10
PK - Pakistan 8
CH - Svizzera 7
JM - Giamaica 6
MA - Marocco 6
PH - Filippine 6
PY - Paraguay 6
RU - Federazione Russa 6
CO - Colombia 5
EC - Ecuador 5
ID - Indonesia 5
IN - India 5
PL - Polonia 5
VE - Venezuela 5
CR - Costa Rica 4
IE - Irlanda 4
SA - Arabia Saudita 4
SC - Seychelles 4
SE - Svezia 4
TR - Turchia 4
HN - Honduras 3
KE - Kenya 3
NL - Olanda 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
AL - Albania 2
BE - Belgio 2
CL - Cile 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ES - Italia 2
GT - Guatemala 2
HR - Croazia 2
KZ - Kazakistan 2
MD - Moldavia 2
NI - Nicaragua 2
PE - Perù 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
UA - Ucraina 1
VC - Saint Vincent e Grenadine 1
VG - Isole Vergini Britanniche 1
Totale 11.259
Salva come PNG Salva come JPEG
Città #
Genova 4.298
Genoa 2.706
Rapallo 737
Vado Ligure 620
San Jose 295
Singapore 254
Ashburn 120
Ho Chi Minh City 63
Lauterbourg 59
Council Bluffs 57
Beijing 52
Hanoi 48
New York 48
Hong Kong 37
Helsinki 34
Santa Clara 32
Los Angeles 28
Bordighera 23
Frankfurt am Main 22
Milan 20
Phoenix 19
Tokyo 18
Tianjin 17
Chicago 15
Buffalo 10
Dallas 10
Florence 10
Da Nang 9
Mexico City 9
Houston 8
Rome 8
São Paulo 8
Biên Hòa 7
Boardman 7
Philadelphia 7
Toronto 7
Turin 7
Guangzhou 6
North Bergen 6
Padua 6
Salt Lake City 6
Zurich 6
Des Moines 5
Haiphong 5
Hangzhou 5
London 5
Warsaw 5
Baghdad 4
City of London 4
Dublin 4
Johannesburg 4
Kingston 4
Naples 4
Newark 4
Orem 4
Phủ Lý 4
Princeton 4
Queens 4
Amsterdam 3
Asunción 3
Birmingham 3
Bologna 3
Bossier City 3
Casablanca 3
Catania 3
Cleveland 3
Davenport 3
Denver 3
Garland 3
Ljubljana 3
Long Xuyen 3
Modesto 3
Montevideo 3
Montreal 3
Nairobi 3
Ninh Bình 3
Phủ Từ Sơn 3
Plymouth 3
Pordenone 3
Rio de Janeiro 3
San Diego 3
Staten Island 3
Washington 3
Wuppertal 3
Alajuela 2
Baltimore 2
Bari 2
Baton Rouge 2
Bear 2
Belgrade 2
Belo Horizonte 2
Bogotá 2
Borghetto di Vara 2
Boston 2
Brooklyn 2
Brownsville 2
Brussels 2
Cagliari 2
Camerino 2
Cardiff 2
Totale 9.938
Salva come PNG Salva come JPEG
Nome #
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 283
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 254
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools 244
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 228
Benzimidazole derivatives endowed with potent antileishmanial activity 225
Acridine derivatives as anti-BVDV agents 217
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 214
Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents 212
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 209
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 195
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 194
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities 193
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 191
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 184
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation 184
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 182
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 181
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 180
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 179
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 179
The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study 176
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents 172
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 171
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 168
New coumarin hybrids with antiproliferative activity against a neuroblastoma cell line 167
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 166
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 163
N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes 162
Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal 161
Computational approaches for the design and chemical synthesis of novel F508del correctors in the treatment of cystic fibrosis 159
New arylsparteine derivatives as positive inotropic drugs 158
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 158
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 157
Synthesis and pharmacological evaluation of some thiolupinine derivatives 155
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 148
Short exposure to high concentrations of malondialdehyde does not mimic physiological conditions 145
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 145
Synthesis, binding, and modeling studies of new cytisine derivatives as ligands for neuronal nicotinic acetylcholine receptor subtypes 144
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as potential potentiators of the chloride transport defect in cystic fibrosis 144
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 141
Cap 10 - Recettori adrenergici e farmaci attivi sulla neurotrasmissione adrenergica 141
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays 141
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays 140
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 139
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease 139
Cap 16 - Anestetici generali ed anestetici locali 135
Btk inhibitors: a medicinal chemistry and drug delivery perspective 134
Journey on naphthoquinone and anthraquinone derivatives: New insights in alzheimer’s disease 132
Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction 126
Novel organotins as antitumor agents 120
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 117
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors 117
Cap 11 - Recettori della serotonina e farmaci attivi sulla neurotrasmissione serotoninergica 115
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 113
Cap. 9 - Farmaci attivi sulla neurotrasmissione colinergica 110
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 108
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives 105
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 105
Microbiological Screening of 5-Functionalized Pyrazoles for the Future Development of Optimized Pyrazole-Based Delivery Systems 104
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis 103
New pyrazolyl thioureas active against the Staphylococcus genus 94
BMI-1 inhibition fights cancer chemoresistance by altering redox homeostasis and inducing lipid peroxidation 94
Quinone-based derivatives: a new class of multi-target agents against Alzheimer’s disease 93
Glutathione in cancer progression and chemoresistance: an update 87
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-([Formula: see text]-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines. 87
Design and synthesis of new coumarin hybrids with antiproliferative activity against neuroblastoma cells 85
The Development of FAK Inhibitors: A Five-Year Update 84
Synthesis and prelimary docking studies of new colchicine-benzotriazole hybrid compounds 83
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells 82
Indole Antitumor Agents in Nanotechnology Formulations: An Overview 81
Further quinolizidine derivatives as antiarrhythmic agents-3 79
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells 79
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 77
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 76
New naphtho- and anthraquinone derivatives as Cholinesterase inhibitors for the treatment of Alzheimer's disease 69
New insights on Fak and Fak inhibitors 68
NEW HYBRID COUMARIN–SUBSTITUTED ALICYCLIC AMINES AS POTENTIAL MULTITARGET DIRECT LIGANDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 64
Hybrid molecules phenothiazine/cinnamic derivatives as MTDL and their biological evaluation 56
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells 56
Nanotechnology for Pediatric Retinoblastoma Therapy 52
SYNTHESIS AND STRUCTURE–ACTIVITY RELATIONSHIP OF COUMARIN HYBRIDS WITH ANTIPROLIFERATIVE PROPERTIES AGAINST A MULTIDRUG-RESISTANT NEUROBLASTOMA CELL LINE 42
null 38
Nanotechnology of tyrosine kinase inhibitors in cancer therapy: A perspective 36
New hybrids coumarins– substituted alicyclic amines as potential multi target direct ligands for the treatment of Alzheimer’s disease 34
The Development of BTK Inhibitors: A Five-Year Update 33
null 28
Totale 11.489
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.799
article - articoli 32.313
book - libri 0
conference - conferenze 3.942
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.544
Totale 75.598
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022780 0 0 79 83 31 46 47 190 46 69 48 141
2022/2023860 74 55 15 91 155 151 4 57 140 5 101 12
2023/2024512 21 86 19 82 27 70 20 46 19 17 55 50
2024/20251.716 41 106 58 96 210 180 195 310 66 76 193 185
2025/20263.435 395 86 324 340 461 224 484 200 255 345 160 161
2026/2027525 288 139 98 0 0 0 0 0 0 0 0 0
Totale 11.489